Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine

Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Alflen, Cylie, Birch, Katheryn, Shilian, Ryan, Wu, Shan Shan, Hostoffer, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236777/
https://www.ncbi.nlm.nih.gov/pubmed/34249404
http://dx.doi.org/10.1177/21526567211026271
_version_ 1783714612431028224
author Alflen, Cylie
Birch, Katheryn
Shilian, Ryan
Wu, Shan Shan
Hostoffer, Robert
author_facet Alflen, Cylie
Birch, Katheryn
Shilian, Ryan
Wu, Shan Shan
Hostoffer, Robert
author_sort Alflen, Cylie
collection PubMed
description Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive agents may be administered. Exacerbating factors include stress, environmental conditions, medications, physical stimuli, and infections. We report the first two cases of a COVID-19 vaccine triggered relapse of CSU that was previously well controlled on therapy.
format Online
Article
Text
id pubmed-8236777
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82367772021-07-08 Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine Alflen, Cylie Birch, Katheryn Shilian, Ryan Wu, Shan Shan Hostoffer, Robert Allergy Rhinol (Providence) Case Report Chronic spontaneous urticaria (CSU, chronic idiopathic urticaria) is a clinical diagnosis characterized by recurrent urticaria of unknown origin, with or without angioedema, that occurs for six weeks or longer. Management of CSU includes a second-generation H1 antihistamine and/or elimination of exacerbating factors. If initial treatment is unsuccessful, trials of first generation H1 antihistamine, H2 blocking antihistamine, leukotriene-receptor antagonist, anti-inflammatory or immunosuppressive agents may be administered. Exacerbating factors include stress, environmental conditions, medications, physical stimuli, and infections. We report the first two cases of a COVID-19 vaccine triggered relapse of CSU that was previously well controlled on therapy. SAGE Publications 2021-06-24 /pmc/articles/PMC8236777/ /pubmed/34249404 http://dx.doi.org/10.1177/21526567211026271 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Alflen, Cylie
Birch, Katheryn
Shilian, Ryan
Wu, Shan Shan
Hostoffer, Robert
Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
title Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
title_full Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
title_fullStr Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
title_full_unstemmed Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
title_short Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine
title_sort two cases of well controlled chronic spontaneous urticaria triggered by the moderna covid-19 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236777/
https://www.ncbi.nlm.nih.gov/pubmed/34249404
http://dx.doi.org/10.1177/21526567211026271
work_keys_str_mv AT alflencylie twocasesofwellcontrolledchronicspontaneousurticariatriggeredbythemodernacovid19vaccine
AT birchkatheryn twocasesofwellcontrolledchronicspontaneousurticariatriggeredbythemodernacovid19vaccine
AT shilianryan twocasesofwellcontrolledchronicspontaneousurticariatriggeredbythemodernacovid19vaccine
AT wushanshan twocasesofwellcontrolledchronicspontaneousurticariatriggeredbythemodernacovid19vaccine
AT hostofferrobert twocasesofwellcontrolledchronicspontaneousurticariatriggeredbythemodernacovid19vaccine

Ejemplares similares